Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: SICAV
  • Objective: Developed Markets
  • Asset Class: Equity
  • Geographic Focus: Global

Capital Group Global Equity Fnd

+ Add to Watchlist

CIGEBDC:LX

20.42 CHF 0.33 1.59%

As of 13:44:49 ET on 03/26/2015.

Snapshot for Capital Group Global Equity Fnd (CIGEBDC)

Year To Date: -1.86% 3-Month: -1.82% 3-Year: +13.22% 52-Week Range: 17.38 - 21.43
1-Month: -1.26% 1-Year: +12.87% 5-Year: +5.97% Beta vs M1WO: 0.99

Mutual Fund Chart for CIGEBDC

No chart data available.
  • CIGEBDC:LX 20.42
  • 1M
  • 1Y
Interactive CIGEBDC Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for CIGEBDC

Capital Group Global Equity Fund is a SICAV incorporated in Luxembourg. The Fund's objective is long term growth through investment primarily in listed Equity, researched and selected on a world-wide basis.

Inception Date: 08-31-2004 Telephone: 352-46-2685-611
Managers: NILLY SILKORSKY / RUDOLF STAEHELIN
Web Site: www.thecapitalgroup.com

Fundamentals for CIGEBDC

NAV (on 2015-03-26) 20.42
Assets (M) (on 2015-03-26) 695.56
Fund Leveraged N
Minimum Investment 1,000.00
Minimum Subsequent Investment -

Dividends for CIGEBDC

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2015-01-02) 0.33
Dividend Yield (ttm) 1.63

Fees & Expenses for CIGEBDC

Front Load 5.25
Back Load 0.00
Current Mgmt Fee 1.50
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 1.89

Top Fund Holdings for CIGEBDC

Filing Date: 12/31/2014
Name Position Value % of Total
Goldman Sachs Group Inc/The 167,100 26,946,858 2.975%
Gilead Sciences Inc 278,620 22,192,011 2.450%
Roche Holding AG 82,049 18,418,034 2.034%
Novo Nordisk A/S 524,527 18,334,103 2.024%
Chevron Corp 192,822 17,785,966 1.964%
Pernod Ricard SA 170,670 15,746,014 1.738%
Incyte Corp 243,631 14,845,138 1.639%
Unilever NV 436,109 14,234,598 1.572%
ASML Holding NV 153,370 13,726,615 1.516%
AIA Group Ltd 2,970,600 13,626,676 1.504%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil